Pacific Biosciences Of California (PACB) Work In Process (2011 - 2026)

Pacific Biosciences Of California has reported Work In Process for 16 years, with the latest figure at $27.3 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 9.77% year-over-year to $27.3 million; the trailing twelve-month figure through Mar 2026 stood at $27.3 million (up 9.77% YoY), and the FY2025 full-year result was $27.1 million, up 22.01% from the prior year.
• Work In Process for Q1 2026 stood at $27.3 million, up from $27.1 million in the prior quarter.
• The five-year high for Work In Process was $27.9 million in Q3 2023, with the low at $9.2 million in Q1 2022.
• Average Work In Process over 5 years is $21.7 million, with a median of $22.6 million recorded in 2023.
• Year-over-year, Work In Process jumped 135.87% in 2023 and slumped 34.4% in 2024.
• Tracing PACB's Work In Process over 5 years: stood at $14.1 million in 2022, then soared by 96.65% to $27.7 million in 2023, then fell by 19.82% to $22.2 million in 2024, then grew by 22.01% to $27.1 million in 2025, then rose by 1.1% to $27.3 million in 2026.
• The last three Work In Process figures came in at $27.3 million (Q1 2026), $27.1 million (Q4 2025), and $25.2 million (Q3 2025), per Business Quant data.

Peer Comparison